Fulailin Saxagliptin Tablets Package Insert

Package insert for Fulailin saxagliptin tablets covering ingredients, indications, dosage including renal impairment, and adverse reactions.


Fulailin Saxagliptin Tablets Package Insert - cover page
Brand
孚来霖
Category
Drugs
Document type
User Manual
Language
Chinese
Pages
16
File format
PDF
File size
995 KB
Published
16 November, 2026
Updated
16 November, 2026
MD5 checksum
502A3DF546D5558F426A1263B0A1E259

About this manual

This is the Chinese package insert (说明书) for Fulailin saxagliptin tablets (沙格列汀片), a medicine whose active ingredient is saxagliptin, with a monohydrate molecular formula of C18H25N3O2·H2O and a molecular weight of 333.43 for the monohydrate and 315.41 for the anhydrous free base. The document carries an approval date of October 27, 2020 and revision dates of May 31, 2021 and June 11, 2024. It is available in two strengths, 2.5 mg (yellow film-coated tablet) and 5 mg (off-white film-coated tablet).

The stated indication is type 2 diabetes, used as monotherapy or in combination with metformin or insulin, and it is not intended for type 1 diabetes or diabetic ketoacidosis. The recommended oral dose is 5 mg once daily regardless of meals, and the tablet must not be cut or split; patients with eGFR below 45 mL/min/1.73 m2 should be limited to 2.5 mg once daily. The insert also reports clinical trial adverse reactions such as upper respiratory tract infection, urinary tract infection, headache, hypoglycemia, peripheral edema and hypersensitivity events. This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 性状
  • 适应症
  • 规格
  • 用法用量
  • 不良反应

Specifications

Active ingredientSaxagliptin (沙格列汀)
Molecular formulaC18H25N3O2·H2O
Molecular weight333.43 (monohydrate); 315.41 (anhydrous free base)
Strengths2.5 mg and 5 mg
Appearance, 2.5 mgYellow film-coated tablet, white after coating is removed
Appearance, 5 mgOff-white film-coated tablet, white after coating is removed

Frequently asked questions

What is Fulailin saxagliptin tablets used for?

The stated indication is type 2 diabetes; it can be used as monotherapy or in combination with metformin or insulin.

What is the recommended dose?

The recommended oral dose is 5 mg once daily, and the timing does not depend on meals.

Can the tablet be split or cut?

No, the tablet must not be cut or split.

What dose is used in patients with reduced kidney function?

Patients with eGFR below 45 mL/min/1.73 m2 should have the dose adjusted to 2.5 mg once daily.

Download PDF (995 KB)